Search Results - "BIGAUD, Marc"
-
1
Second generation S1P pathway modulators: Research strategies and clinical developments
Published in Biochimica et biophysica acta (01-05-2014)“…Multiple Sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system (CNS) through demyelination and neurodegeneration. Until…”
Get full text
Journal Article -
2
Impact of Siponimod on Enteric and Central Nervous System Pathology in Late-Stage Experimental Autoimmune Encephalomyelitis
Published in International journal of molecular sciences (17-11-2022)“…Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). Although immune modulation and suppression are effective during…”
Get full text
Journal Article -
3
Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration
Published in Frontiers in immunology (28-07-2022)“…Approval of B-cell-depleting therapies signifies an important advance in the treatment of multiple sclerosis (MS). However, it is unclear whether the…”
Get full text
Journal Article -
4
Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: Preclinical insights
Published in Multiple sclerosis journal - experimental, translational and clinical (01-10-2021)“…Background Siponimod (BAF312), a selective S1P1/S1P5 agonist, reduces disability progression in secondary progressive MS. Recent observations suggest it could…”
Get full text
Journal Article -
5
Siponimod is a Functional Agonist for the S1P5 Receptor (P3.404)
Published in Neurology (10-04-2018)“…Abstract only…”
Get full text
Journal Article -
6
Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology
Published in Frontiers in immunology (30-04-2020)“…Genetic disruption or short-term pharmacological inhibition of MALT1 protease is effective in several preclinical models of autoimmunity and B cell…”
Get full text
Journal Article -
7
Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism
Published in PloS one (22-12-2016)“…Homeostasis of vascular barriers depends upon sphingosine 1-phosphate (S1P) signaling via the S1P1 receptor. Accordingly, S1P1 competitive antagonism is known…”
Get full text
Journal Article -
8
Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?
Published in Neurology and therapy (01-08-2023)“…Introduction Siponimod, a potent and selective sphingosine-1-phosphate (S1P 1,5 ) agonist, is the only therapeutic agent that has shown efficacy against…”
Get full text
Journal Article -
9
Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis
Published in PloS one (27-03-2013)“…Sphingosine-1-phosphate (S1P) regulates the egress of T cells from lymphoid organs; levels of S1P in the tissues are controlled by S1P lyase (Sgpl1). Hence,…”
Get full text
Journal Article -
10
Reduced cardiac side-effect potential by introduction of polar groups: Discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivo
Published in Bioorganic & medicinal chemistry (15-03-2008)“…Introduction of polar groups in a series of potent CCR5 antagonists which are very likely to adversely affect the conduction system in the heart led to the…”
Get full text
Journal Article -
11
Gene expression profiling of immunomagnetically separated cells directly from stabilized whole blood for multicenter clinical trials
Published in Clinical and translational medicine (13-11-2014)“…Background Clinically useful biomarkers for patient stratification and monitoring of disease progression and drug response are in big demand in drug…”
Get full text
Journal Article -
12
Meta-analysis for Neurofilament Light Chain as a Biomarker in Mouse Experimental Autoimmune Encephalomyelitis Studies (S17.008)
Published in Neurology (09-04-2024)“…Abstract only…”
Get full text
Journal Article -
13
Comparative Pharmacology of Ofatumumab vs Ocrelizumab in Humanized CD20 Transgenic Mice (S9.007)
Published in Neurology (25-04-2023)“…Abstract only…”
Get full text
Journal Article -
14
Siponimod Penetrates, Distributes and Acts on the Central Nervous System: Translational Insights (3973)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
15
Siponimod: From Understanding Mode of Action to Differentiation Versus Fingolimod (1536)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
16
Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome
Published in Annals of the rheumatic diseases (01-07-2019)“…To examine the role of CD40-CD154 costimulation and effects of therapeutic pathway blockade in the non-obese diabetic (NOD/ShiLtJ) model of Sjögren's syndrome…”
Get more information
Journal Article -
17
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence
Published in Journal of interferon & cytokine research (01-06-2023)“…Maladjusted immune responses to the coronavirus disease 2019 (COVID-19), for example, cytokine release syndrome, may result in immunopathology and acute…”
Get more information
Journal Article -
18
Pharmacokinetic/Pharmacodynamic Characterization of Siponimod (BAF312) in Blood versus Brain in Experimental Autoimmune Encephalomyelitis Mice (P2.2-066)
Published in Neurology (09-04-2019)“…Abstract only…”
Get full text
Journal Article -
19
A simple method to optimize peripheral blood mononuclear cell preparation from cynomolgus monkeys and improve mixed lymphocyte reactions
Published in Journal of pharmacological and toxicological methods (01-09-2004)“…Introduction: The standard Ficoll–Hypaque method used to isolate peripheral blood mononuclear cells (PBMC) gives very variable results when used with…”
Get full text
Journal Article -
20
Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation
Published in The Journal of immunology (1950) (15-04-2015)“…The paracaspase MALT1 plays an important role in immune receptor-driven signaling pathways leading to NF-κB activation. MALT1 promotes signaling by acting as a…”
Get full text
Journal Article